Syncromune, Inc.

Amendment
CIK: 0001955312·Biotechnology·DELAWARE·Filed: Aug 21, 2025
Total Offering

$144,828,791

Amount Sold

$111,828,793

Investors

77

First Sale

Dec 3, 2024

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2020
Non-Accredited Investors
No

Related Persons

NameRole
Agustin Gago
Related Person
Joseph Gerardi
Related Person
Charles J. Link
Related Person
Jeffrey L. Cleland
Related Person
Joseph C. Maroon
Related Person
Kerri-Ann Millar
Related Person
Norman Schwartz
Related Person
Douglas G. Watson
Related Person
Eamonn Hobbs
Related Person

Company

Syncromune, Inc.

2919 E. COMMERCIAL BLVD., SUITE 200

FORT LAUDERDALE, FL, 33308

518-796-6110

SEC Filing

0001231919-25-000158

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free